Priority Date: 24.07.12 (US 201261675276P)

A NOVEL METHOD TO DETECT RESISTANCE TO CHEMOTHERAPY IN PATIENTS WITH LUNG CANCER

  • Application ID: EP13822940
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

operating since 1995
1212.12
Headquarter in Leeds and 14 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 24.07.2012 - Priority Date (US 201261675276P)
  • 30.01.2014 - Publication A2 (WO2014018683)
  • 03.06.2015 - Publication A2 (EP2877210)